Alopecia areata is a medical disease - 14/03/18
Doi : 10.1016/j.jaad.2017.09.011
Dorota Z. Korta, MD a, Angela M. Christiano, PhD b, Wilma Bergfeld, MD c, Madeleine Duvic, MD d, Abby Ellison, BA e, Jennifer Fu, MD f, John E. Harris, MD, PhD g, Maria K. Hordinsky, MD h, Brett King, MD, PhD i, Dory Kranz, MA e, Julian Mackay-Wiggan, MD b, Amy McMichael, MD j, David A. Norris, MD k, Vera Price, MD f, Jerry Shapiro, MD l, Natasha Atanaskova Mesinkovska, MD, PhD a, e, ⁎ 
a Department of Dermatology, University of California Irvine, Irvine, California
b Departments of Dermatology and Genetics and Development, Columbia University, New York, New York
c Department of Dermatology, Cleveland Clinic, Cleveland, Ohio
d Department of Dermatology, The University of Texas MD Anderson Cancer Center, Houston, Texas
e National Alopecia Areata Foundation, San Rafael, California
f Department of Dermatology, University of California San Francisco, San Francisco, California
g Department of Dermatology, University of Massachusetts Medical School, Worcester, Massachusetts
h Department of Dermatology, University of Minnesota Medical School, Minneapolis, Minnesota
i Department of Dermatology, Yale School of Medicine, New Haven, Connecticut
j Department of Dermatology, Wake Forest Baptist Medical Center, Winston-Salem, North Carolina
k Department of Dermatology, University of Colorado Anschutz Medical Campus, Aurora, Colorado
l The Ronald O. Perelman Department of Dermatology, New York University School of Medicine, New York, New York
∗Reprint requests: Natasha Atanaskova Mesinkovska, MD, PhD, University of California Irvine, Department of Dermatology, Gottschalk Medical Plaza, 1 Medical Plaza Dr, Irvine, CA 92697.University of California IrvineDepartment of DermatologyGottschalk Medical Plaza, 1 Medical Plaza DrIrvineCA92697
Key words : alopecia areata, autoimmune, burden, insurance, patient outcomes, quality of life, reimbursement
Abbreviations used : AA, QoL
Le texte complet de cet article est disponible en PDF.
| Dr Mackay-Wiggan is currently affiliated with Siperstein Dermatology, Boynton Beach, Florida. |
|
| Funding sources: None. |
|
| Conflicts of interest: None disclosed. |
© 2017
American Academy of Dermatology, Inc.. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 78 - N° 4
P. 832-834 - avril 2018 Retour au numéro
Article précédent
- Billing of botulinum toxin for hyperhidrosis: Ethical considerations
- Hannah J. Anderson, Matthew Keller
- Beyond JAAD April 2018: Articles of interest to dermatologists from the nondermatologic literature
- Andrew Bronin, Robert Phelps, Robert Sidbury
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?